Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
Clinical trial NCT02799238 · COMPLETED
Trial details
- NCT number
- NCT02799238
- Sponsor
- CytoVac A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2019-11-14
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.